Wahid, L., Froess, J. D., Ortel, T. L., Zarychanski, R., Berger, J. S., Cushman, M., … Lawler, P. R. (2025). On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19. Arterioscler Thromb Vasc Biol, 45(1), 162–164. https://doi.org/10.1161/ATVBAHA.124.321108

Wahid, Lana, Joshua D. Froess, Thomas L. Ortel, Ryan Zarychanski, Jeffrey S. Berger, Mary Cushman, Derek C. Angus, et al. “On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19.” Arterioscler Thromb Vasc Biol 45, no. 1 (January 2025): 162–64. https://doi.org/10.1161/ATVBAHA.124.321108.

Wahid L, Froess JD, Ortel TL, Zarychanski R, Berger JS, Cushman M, et al. On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19. Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):162–4.

Wahid, Lana, et al. “On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19.” Arterioscler Thromb Vasc Biol, vol. 45, no. 1, Jan. 2025, pp. 162–64. Pubmed, doi:10.1161/ATVBAHA.124.321108.

Wahid L, Froess JD, Ortel TL, Zarychanski R, Berger JS, Cushman M, Angus DC, Renard V, Farahani P, Webb S, Heath A, Godoy LC, Farkouh ME, Hochman JS, Neal MD, Lawler PR. On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19. Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):162–164.